An affiliate of Sun European Partners, LLP has entered into an agreement to acquire NextPharma Technologies Holding Ltd., a global provider of contract manufacturing, product development, clinical trials and logistics services to the pharmaceutical and biotechnology industry.

Headquartered in Surrey, UK, NextPharma provides a range of services from drug development to manufacturing and distribution supply chain. The company has seven manufacturing facilities, seven product development centers and six temperature-controlled storage and distribution sites across Europe and the
U.S.

Bill Wedlake, chief executive officer of NextPharma said: “For many years we have worked closely with our customers to develop a full range of integrated pharmaceutical development, manufacturing and logistics services to provide flexibility and confidence through high levels of quality and customer service. We are excited to work with Sun European Partners to continue to grow the company and to expand into innovative new technologies and markets.”

Matthias Gundlach, vice president of Sun European Partners added, “The pharmaceutical industry is increasingly using drug development and manufacturing outsourcing. NextPharma, with its strong track record, reputation and state of the art facilities, is well positioned to capitalise on these trends. We see significant opportunity to grow the business both organically and by acquisitions and look forward to working with management to achieve this potential.”